DE60222390D1 - Verbessertes in-vitro-synthesesystem - Google Patents

Verbessertes in-vitro-synthesesystem

Info

Publication number
DE60222390D1
DE60222390D1 DE60222390T DE60222390T DE60222390D1 DE 60222390 D1 DE60222390 D1 DE 60222390D1 DE 60222390 T DE60222390 T DE 60222390T DE 60222390 T DE60222390 T DE 60222390T DE 60222390 D1 DE60222390 D1 DE 60222390D1
Authority
DE
Germany
Prior art keywords
hydrolysis
vitro synthesis
improved
synthesis system
bonds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60222390T
Other languages
English (en)
Other versions
DE60222390T2 (de
Inventor
Deb K Chatterjee
Mary C Longo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Corp
Original Assignee
Invitrogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invitrogen Corp filed Critical Invitrogen Corp
Application granted granted Critical
Publication of DE60222390D1 publication Critical patent/DE60222390D1/de
Publication of DE60222390T2 publication Critical patent/DE60222390T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Vibration Dampers (AREA)
  • Feeding, Discharge, Calcimining, Fusing, And Gas-Generation Devices (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DE60222390T 2001-03-08 2002-03-07 Verbessertes in-vitro-synthesesystem Expired - Lifetime DE60222390T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27382701P 2001-03-08 2001-03-08
US273827P 2001-03-08
PCT/US2002/006812 WO2002072890A1 (en) 2001-03-08 2002-03-07 Improved in vitro synthesis system

Publications (2)

Publication Number Publication Date
DE60222390D1 true DE60222390D1 (de) 2007-10-25
DE60222390T2 DE60222390T2 (de) 2008-06-19

Family

ID=23045560

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60222390T Expired - Lifetime DE60222390T2 (de) 2001-03-08 2002-03-07 Verbessertes in-vitro-synthesesystem

Country Status (8)

Country Link
US (1) US20020168706A1 (de)
EP (1) EP1373570B1 (de)
JP (1) JP4328530B2 (de)
AT (1) ATE373102T1 (de)
CA (1) CA2440531A1 (de)
DE (1) DE60222390T2 (de)
NZ (1) NZ528342A (de)
WO (1) WO2002072890A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030119091A1 (en) * 2001-12-20 2003-06-26 Toru Ezure Cell-free protein synthesis method and extract solution therefor
WO2004096999A2 (en) * 2003-04-28 2004-11-11 Exelixis, Inc. In vitro translation system
WO2004111203A1 (ja) * 2003-06-10 2004-12-23 Shimadzu Corporation 哺乳動物培養細胞抽出液およびその調製方法、ならびに該抽出液を用いた無細胞系タンパク質合成方法
WO2005033286A2 (en) 2003-10-01 2005-04-14 Invitrogen Corporation Compositions and methods for synthesizing, purifying and detecting biomolecules
JP4091901B2 (ja) * 2003-11-13 2008-05-28 株式会社島津製作所 無細胞系タンパク質合成におけるミクロソーム膜添加による翻訳後修飾方法
DK1685240T3 (en) * 2003-11-20 2015-02-16 Univ Leland Stanford Junior Improved methods for in vitro protein synthesis
US20070117179A1 (en) * 2005-09-27 2007-05-24 Invitrogen Corporation In vitro protein synthesis systems for membrane proteins that include adolipoproteins and phospholipid-adolipoprotein particles
EP2118129A4 (de) * 2007-03-01 2010-04-28 Life Technologies Corp Isolierte phospholipidproteinpartikel
WO2014176439A1 (en) * 2013-04-25 2014-10-30 Sutro Biopharma, Inc. The use of lambda-gam protein in ribosomal display technology
AU2020328511A1 (en) 2019-08-09 2022-03-03 Nutcracker Therapeutics, Inc. Methods and apparatuses for manufacturing for removing material from a therapeutic composition
US11839881B2 (en) 2021-02-25 2023-12-12 Ardent Mills, Llc Systems and methods for extracting and isolating purified wheat embryo products

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665563A (en) * 1991-10-11 1997-09-09 Promega Corporation Coupled transcription and translation in eukaryotic cell-free extract
EP0566714B1 (de) * 1991-10-11 1997-01-02 Promega Corporation Gekoppelte transkription und translation in zellfreien eukaryoten-extrakten
JP3434319B2 (ja) * 1993-06-15 2003-08-04 日本製粉株式会社 無細胞タンパク合成系によるタンパクの製造方法
EP1177311B1 (de) * 1999-03-17 2014-11-12 The Board Of Trustees Of The Leland Stanford Junior University IN VITRO MAKROMOLEKüLBIOSYNTHESEVERFAHREN UNTER VERWENDUNG VON EXOGENEN AMINOSäUREN UND ATP-REGENERATIONSSYSTEM
US6168931B1 (en) * 1999-03-17 2001-01-02 The Board Of Trustees Of The Leland Stanford Junior University Enhanced in vitro synthesis of biological macromolecules using a novel ATP regeneration system
EP1220944B1 (de) * 1999-09-24 2010-09-15 Ambion, Inc. Cocktail von nukleaseinhibitoren

Also Published As

Publication number Publication date
US20020168706A1 (en) 2002-11-14
EP1373570B1 (de) 2007-09-12
DE60222390T2 (de) 2008-06-19
EP1373570A4 (de) 2005-04-27
ATE373102T1 (de) 2007-09-15
JP4328530B2 (ja) 2009-09-09
WO2002072890A1 (en) 2002-09-19
EP1373570A1 (de) 2004-01-02
JP2004524847A (ja) 2004-08-19
CA2440531A1 (en) 2002-09-19
WO2002072890A8 (en) 2003-03-13
NZ528342A (en) 2005-10-28

Similar Documents

Publication Publication Date Title
TR200103216T2 (tr) Pirimidinon bileşimleri
DK1117771T3 (da) Tørstofformige phytasesammensætninger
UY26205A1 (es) Derivados de indoloxoacetil piperazina antiviricos
DE60222390D1 (de) Verbessertes in-vitro-synthesesystem
BR9908280A (pt) Inibidores de enzimas de fosfolipase
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
EA200300963A1 (ru) Улучшенный антипирен
AU2002359522A1 (en) Compositions and methods of selective nucleic acid isolation
ATE431416T1 (de) Enzymatische synthese von deoxyribonucleotiden
AU2003299585A1 (en) Water-soluble products and methods of making and using the same
AU2482800A (en) Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
ATE278799T1 (de) Galactomannan-oligosaccharide und verfahren zu deren herstellung sowie deren verwendung
EE9900105A (et) Bensonaftüridiinid bronhiaalravimitena
AU5630999A (en) Endofucanases and method using same for preparing fuco-oligosaccharides from fucanes, bacterium producing endofucanases and uses of fuco-oligosaccharides for plant protection
PT1165558E (pt) Derivados de pirimido¬6,1-a|isoquinolina-4-ona
ATE275956T1 (de) Veränderung der dns methyltransferase durch kombinationstherapie
ATE226588T1 (de) Phosphinsäure-derivate
WO2001087898A3 (de) N- (2-pyrimidinyl) (thio)phosphorsäuretriamide, verfahren zu ihrer herstellung, und deren verwendung als mittel zur regulierung bzw. hemmung der enzymatischen harnstoff-hydrolyse
PT1080104E (pt) Certos tiois heteroarilo substituidos inibidores da enzima conversora da endotelina
AP2000001984A0 (en) Combination of protein farnesyltrandferase and HMG COA reductase inhibitors and their use to treat cancer.
DE50110723D1 (de) Isolierte luziferasen sowie deren verwendung
BR0114884A (pt) Compostos calcilìticos
MXPA04002041A (es) Procedimiento para la obtencion de suspensiones aceitosas de enzimas solubles en agua.
ES2171653T3 (es) Composiciones que poseen propiedades antivirales y procedimiento de obtencion.
AU2001260314A1 (en) Method for selecting enzyme inhibitors

Legal Events

Date Code Title Description
8364 No opposition during term of opposition